You are on page 1of 10

Ultrasonics - Sonochemistry 55 (2019) 57–66

Contents lists available at ScienceDirect

Ultrasonics - Sonochemistry
journal homepage: www.elsevier.com/locate/ultson

A facile ultrasonic-aided biosynthesis of ZnO nanoparticles using Vaccinium T


arctostaphylos L. leaf extract and its antidiabetic, antibacterial, and oxidative
activity evaluation

Abolfazl Bayramia, , Sanaz Alioghlia, Shima Rahim Pouranb, Aziz Habibi-Yangjehc,

Alireza Khataeed,e, S. Rameshb,
a
Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran
b
Centre of Advanced Manufacturing and Materials Processing, Department of Mechanical Engineering, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur,
Malaysia
c
Department of Chemistry, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran
d
Research Laboratory of Advanced Water and Wastewater Treatment Processes, Department of Applied Chemistry, Faculty of Chemistry, University of Tabriz, 51666-
16471 Tabriz, Iran
e
Department of Materials Science and Nanotechnology Engineering, Faculty of Engineering, Near East University, 99138 Nicosia, North Cyprus, Mersin 10, Turkey

A R T I C LE I N FO A B S T R A C T

Keywords: The synthesis of nanoparticles often result in the generation of harmful chemical pollutants. As such, many
Bactericidal effect researchers have focused on developing green processes, which include the biosynthesis. In this research, ZnO
Bio-extract nanoparticles were prepared using the leaf extract of whortleberry (Vaccinium arctostaphylos L.) via a simple
Decolorization ultrasonic-assisted method. The morphology, crystal size and structure, surface, thermal, and optical properties
Diabetes mellitus
of the bio-mediated ZnO sample (ZnOext) were analyzed and compared with that produced without in-
Nanocatalyst
Ultrasound
corporating the extract (ZnOchem). The ZnO samples were evaluated for their antidiabetic, antibacterial, as well
as their sono- and photo-catalytic performances. Initially, the samples were intraperitoneal injected to alloxan-
diabetic rats to examine their treatment efficiency in terms of effects on fasting blood glucose, insulin, choles-
terol, high-density lipoprotein, and total triglyceride levels. The ZnOext showed significantly higher efficiency for
improving the health status of alloxan-diabetic rats in contrast with other tested treatments, vis. ZnOchem, in-
sulin, and only leaf extract. In addition, both the ZnO samples were assessed against gram-negative and gram-
positive bacteria and through sono- and photo-catalytic processes for removing rhodamine B, respectively. The
results of this study indicated that not only the ZnOext sample was pollution free, it also exhibited higher po-
tentials for treating diabetic rats, bacterial decontamination, and also oxidative removal of organic compounds
under the influences of ultrasound and UV irradiations when compared with ZnOchem sample.

1. Introduction resistance, and possess exceptional absorption filter [5]. Moreover, it


has exhibited satisfactory activity against harmful bacteria and cancer
Today, nanotechnology is employed in almost every field of re- cells coming from its ability in producing reactive oxygen species [6].
search [1]. In parallel, nanomaterials have demonstrated the potential In recent years, plant-mediated synthesis has become a more pop-
to appoint a great impact on the quality of life of individuals with ular method for ZnO production owing to be safe, simple, effective, and
health problems [2]. In this regard, there is a growing body of literature environmentally benign [7]. Plants are natural and plentiful source of
on the application of semiconductor oxide nanoparticles in scientific secondary metabolites, which offer unique therapeutic properties to
processes [3]. Among the semiconductor oxide nanoparticles, zinc improve human health condition. From therapeutic point of view, a
oxide has been one of the greatly studied metal oxides for medicinal number of secondary metabolites such as flavonoids, steroids, tannins,
and environmental applications, since it has been certified as a safe alkaloids, and terpenoids were reported as significant bioactive mole-
substance by food and drug administration (FDA), USA [4]. ZnO na- cules [8]. There are many literatures on the bio-synthesis of ZnO in the
noparticles are resistant to corrosion, have durable anti-oxidation presence of the extract obtained from different parts of plants such as


Corresponding authors.
E-mail addresses: a_bayrami@uma.ac.ir (A. Bayrami), ramesh79@um.edu.my (S. Ramesh).

https://doi.org/10.1016/j.ultsonch.2019.03.010
Received 28 January 2019; Received in revised form 1 March 2019; Accepted 9 March 2019
Available online 11 March 2019
1350-4177/ © 2019 Elsevier B.V. All rights reserved.
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

Scheme 1. Chemical structure of a number of compounds present in the leaf extract of V. arctostaphylos L.

Amaranthus caudatus [9], Silybum marianum L. seed [10], Momordica contact of ZnO with cell membrane and its disruption, which inhibits
charantia [11], Euphorbia prolifera leaf [12], and Ziziphus nummularia the bacterial growth and division [25]. One more mechanism is asso-
leaf [13]. The rich content of plant extract not only performs as capping ciated with the increased solubility of ZnO because of the complexation
agent to control the shape and size and inhibit the aggregation of the of the released Zn2+ ions [26].
ZnO nanoparticles but also it is involved in stabilizing the nanoparticles Besides that, the multifunction ZnO is well-known for its good
while acting as reducing agent [7]. photocatalytic activity. However, an energy larger than ZnO band gap
As reported in the literature, ultrasound irradiation has been em- energy (Eg = 3.37) is required to produce electron-hole pairs in order to
ployed as a promising approach for effective extraction and biosynth- start the oxidation reactions. Alternatively, this n-type semiconductor
esis of ZnO nanoparticles [7]. The use of ultrasonic irradiation has been can be modified through doping with other metals or metal oxides to
effectively launched in the recent decades and is well-prevailing in reduce the corresponding Eg and accordingly, the amount of irradiated
preparation of nanomaterials and therapeutic applications because it is energy [5]. However, the effect of residual organic moieties from green
efficient, safe, and applicable. The interaction of the sound waves of synthesis of ZnO nanoparticles on its photocatalytic activity is not fully
high intensity and frequency with biological systems gives rise to quick understood.
diffusion of solute out to the solvent. The role of ultrasonication in an Caucasian whortleberry (Vaccinium arctostaphylos L.) is a perennial
effective extraction process has been attributed to several mechanisms plant, which commonly grow in Caucasus and western Asia (Iran and
including the enhanced penetration and swelling, hydration process, Turkey). The fruits of this plant has shown beneficial effects on oxi-
disruption of cells or capillary phenomenon [14]. On the other hand, dative stress, and hyperlipidemia [27], while the aqueous extract of its
there has been a surge of interest in the ultrasound-assisted biosynthesis leaves have high levels of phenolic compounds and flavonoids with
of nanoparticles on account of rapid reaction, high efficiency, moderate antidiabetic and anti-hypertensive activities [28]. Quercetin (inhibitory
condition, and generating well-dispersed nanoparticles [15]. effects on the activity of pancreatic α-amylase) [29], Rosmarinic acid,
Diabetes mellitus is described as abnormal secretion or reception of caffeoylarbutin (phenolic compounds) [30], delphinidin, petunidin,
insulin, or post-receptor trials, which affect the metabolism including and malvidin (anthocyanidins) [31] are a number of identified com-
the β cells of the pancreas, liver, and kidney. The common symptoms of pounds in the leaf extract of V. arctostaphylos L. The chemical structure
diabetes are overeating, thirst, and recurrent urination, which are not of these compounds are given in Scheme 1. These compounds promote
typically taken seriously by the patient to think about remedy [16]. In the reduction of the metallic ions if used during the synthesis processes
this regard, a shift in lifestyle toward a healthy diet, doing exercise, and [7].
using hypoglycemic agents are required to control diabetes. For treat- In the present study, a facile and eco-benign approach was adapted
ment purpose, in addition to injectable insulin, some other oral medi- to produce ZnO nanoparticles. For this purpose, an aqueous extract of
cines are also prescribed. However, various complications including Vaccinium arctostaphylos leaf was obtained via ultrasonic-assisted ex-
lactic acidosis, diarrhea, low blood sugar, and liver damage are asso- traction method and used to produce ZnO nanoparticles through a rapid
ciated with these chemical medications [17]. Zinc is considered as a ultrasonic-assisted process, subsequently labeled as ZnOext. The sample
vital trace element in the body that is directly associated with the was characterized by XRD, TEM, SEM, EDX, FT-IR, BET, TGA, and
glucose uptake physiology, partaking in the insulin production, storing, UV–vis DRS techniques and compared with the ZnO sample synthesized
secretion, performance, and transposition inside the cells [18], and without incorporating the extract, labeled as ZnOchem. The activity of
translocation of GLUT4 to cell surface for carrying glucose inside the the samples were evaluated for their efficiency in treating alloxan-in-
insulin-responsive cells [19]. It has been also reported that Zn shows duced diabetic rats, decomposition of gram-positive (Staphylococcus
insulin-like properties, improves insulin mitogenic signaling, and sti- aureus) and gram-negative (Escherichia coli) bacteria, and also deco-
mulates extracellular-signal-regulated kinases 1 and 2 [20,21]. lorization of a dye wastewater (Rhodamine B) through sono- and photo-
ZnO has also demonstrated adequate activities against various pa- catalysis. In antidiabetic studies, the efficiency of ZnOext was compared
thogenic bacteria. The bactericidal effect of ZnO against various pa- to other treatment alternatives, including ZnOchem, insulin, and only
thogens such as Escherichia coli [22], Campylobacter jejuni [23], Pseu- whortleberry extract in relation to diabetic-control (not treated) and a
domonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis [24] are normal healthy group as control. In other studies, the comparisons in
well-documented. Several mechanisms have been reported on ZnO ac- efficacies were made between ZnOext and ZnOchem samples to explore
tion when come in contact with bacteria cells. One frequently reported the best preparation method from environmental, effectiveness, and
reason is production of H2O2 and its consequent oxidative stress on economic points of view.
bacteria cells [23]. Another mechanism is anticipated with the direct

58
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

2. Materials and methods Joyner-Halenda (BJH) models. TGA curves of ZnO samples were col-
lected under air atmosphere using Linseis STA PT 1000 at the rate of
2.1. Materials 10 °C/min from 0 to 700 °C (resolution: 0.1 µg). UV–vis DRS data was
recorded using Scinco 4100 apparatus. The pH measurements were
In this work, the reagents of analytical grade were used without carried out by Metrohm digital pH-meter (model 744).
additional purification. Alloxan monohydrate C4H2N2O4·H2O was ob-
tained from Sigma Aldrich. Zinc nitrate hexahydrate and sodium hy- 2.5. Antidiabetic activities
droxide were purchased from Loba Chemie Company whereas
Rhodamine B (RhB) was procured from Merck. The Vaccinium arctos- The overnight-fasted Wister rats were imposed with diabetes by
taphylos L. leaves were collected from mountain areas located in Ardabil single intraperitoneal injection of 70 mg alloxan per one kg body
province, Iran and validated by a botanist. The determination kits of weight. The hyperglycaemic animals (200–250 mg/dL) were picked for
TG, TC, HDL, and FBS were obtained from Pars Azemoun Company, antidiabetic work. The experiments were conducted for 6 groups of
Iran. Insulin level was established by commercial ELISA kit from five-rat: 1st group (control): typical healthy rats that received saline,
Mercodia, Sweden. Distilled water (DW) was used during the course of 2nd group (Diabetic control): diabetic rats that received physiological
preparation of samples and solutions. saline, 3rd group (insulin): diabetic rats that received 10 U/kg insulin,
4th group (ZnOchem): diabetic rats that received 10 mg/dL of ZnOchem
2.2. Animal testing dissolved in saline, 5th group (EXT): diabetic rats that received plant
extract (150 mg/dL), and 6th group (ZnOext): Diabetic rats that received
Male Wistar rats of about 200 g and one month old, were bought ZnOext dissolved in saline (8 mg/dL). In all the groups, intraperitoneal
from animal house of the University of Tehran. The rats were kept in a injection was daily performed over a period of 16 days. At the end,
standard laboratory (23 ± 2 °C, 50 ± 5% humidity, under a 12 h Ketamine (80 mg/Kg)/Xylazine (15 mg/Kg) was used to anesthetize the
light-12 h dark cycles), and fed with ad libitum laboratory rodent diet overnight-fasted rats. Then, blood samples were procured by heart
(vitamins 3%, lipids 12%. proteins 22%, carbohydrates 30%), and un- puncture, collected in sterile tubes, centrifuged (4000 rpm) for 15 min,
restricted water access. National Institutes of Health (NIH) guidelines and clotting for 30 min. The resultant serum was used to estimate the
were strictly followed to care and work with laboratory animals (NIH FBS, TG, HDL, and TC analysis using commercial testing kits. The in-
Publications No. 8023, revised 1978), under the permission from the sulin level was determined by enzyme-linked immunosorbent assay
Ardabil Animal Care and Use Committee (AACUC). The experiments (ELISA) kits purchased from Mercodia AB, Sweden, using Microplate
involving animal were carried out in the animal laboratory, Department reader, URIT Medical Electronic Co., Ltd, China. All results were sta-
of Biology, Faculty of Basic Sciences, University of Mohaghegh Ardabili. tistically expressed as Mean ± SEM. The significance level of p < 0.05
was considered for all analyses
2.3. Extraction and preparation of ZnO samples
2.6. Antibacterial studies
The whortleberry leaves were washed using double DW, dried in a
dust-free environment at room temperature and then crushed by a The antibacterial activity of the synthesized ZnOchem and ZnOext
grinding mill into a fine powder. About 100 g of the powder was mixed samples were evaluated against both gram-negative and gram-positive
with 200 mL double DW in a 1000 mL-flask. Initially, an ultrasonication bacteria (E. coli and S. aureus, respectively), in Muller-Hinton broth
for 15 min was employed to assist the extraction. The resulted mixtures using serial dilution technique ranging from 0 (control) and 0.05 to
was then heated at 60 °C while stirring on a magnetic heating stirrer 0.8 mg/mL. At length, a number of Muller-Hinton broth tubes were
over a period of 1 h. The mixture was centrifuged (7000 rpm), filtered, mixed by serial double dilution in the indicated range. Subsequently,
and kept in the refrigerator for subsequent applications. the culture media inoculated by the nightlong bacteria culture in Luria-
To prepare ZnOchem sample, Zn (NO3)2·6H2O was dissolved in DW Bertani (LB) broth, and all tubes incubated for a day at 37 °C. Optical
(100 mL) and irradiated by ultrasonic waves for 15 min. The pH of the density at 600 nm was used to verify the antibacterial performance of
mixture was then maintained at 10 using NaOH (5 M) and the sus- the samples in triplicate trials. The percentage of the control was used
pension was irradiated in a domestic microwave oven (Samsung, to express the viability of the bacteria in the nanoparticle-treated cul-
2.45 GHz, 1000 W) for 10 min. The white sediment was then cen- ture. The antibacterial effects of the ZnO samples were calculated and
trifuged at 3000 rpm and washed with DW. Finally, the samples dried in described using minimum inhibitory concentration (MIC) and non-in-
an oven at 333 K overnight. hibitory concentration (NIC) [32]. The inhibited bacteria were reposi-
In the case of ZnOext, 50 mL of extract was diluted with 50 mL of DW tioned to a LB agar in the MIC tubes and checked for their viability.
in a flask. Then Zn (NO3)2·6H2O was added to the extract solution and
irradiated by ultrasound for 15 min. The initial pH of the mixture was 2.7. Catalytic experiments
acidic (5.6), and became basic when NaOH (5 M) drop-wisely added
into the solution. The changes in the pH was evident from the change in In both catalytic processes, 0.1 g of either ZnOext or ZnOchem sample
color (dark green to bright green). The same procedure as ZnOchem was was added into 250 mL of RhB solution (5 ppm) in a 500 mL Erlenmeyer
followed after reaching the pH to 10. flask. During the experiments, the pH of the suspension was not altered
(pH0 ∼6.9). In the sonocatalytic process, an ultrasonic bath was used to
2.4. Characterization sonicate the flask (Sonic Spar 7500S; 20 kHz). During the sonication,
ice-water (2 °C) was added to the bath to prevent the temperature rise
The XRD measurements were carried out using Philips Xpert X-ray due to ultrasonication. During the process, 7 mL of the supernatant was
diffractometer with Cu Kα radiation (λ = 0.15406 nm). The size, shape, sampled with a pipette, centrifuged at 3500 rpm for 5 min and catalyst
and morphology of the samples were observed using the images ob- particles were removed by filtration through a 0.20 μm filter (nylon,
tained from SEM (model LEO1430VP) and TEM (model Zeiss-EM10C Whatman). Afterward, the concentration of residual OTC was measured
180 kV). The same SEM was used to provide the EDX spectra. The FT-IR by a UV–vis spectrophotometer (UNICO-S2100SVIS) at λmax = 553 nm.
analysis was carried out using a Perkin-Elmer Spectrum RXI device. The degradation efficiency (%) was determined by DE% = [(A0 − At)/
Nitrogen adsorption-desorption analysis was conducted to measure the A0] × 100, where, A0 and At are the initial and after t min RhB ab-
specific surface area and pore properties of the samples at −196 °C sorbance.
using Belsorp device and Brunauer-Emmett-Teller (BET) and Barret- The photocatalytic activity of ZnO samples was studied via RhB

59
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

production of ZnO nanoparticles [36]. As for the ZnOext sample, addi-


tional peaks at 1610 and 1255 cm−1 were observed that correspond to
CeH stretching vibrations of CH2 group, and vibration peaks for C]C,
and C]O bonds, respectively [34]. The absorption band of the plant
extract showed a broad peak at 3100–3600 cm−1, which corresponds to
OeH and CeH stretching vibrations, and NeH stretch of amide group.
The sharp peak at 1630 cm−1 is associated with C]C stretch of alkane
group. The peaks at 1220 and 550 cm−1 strongly portrayed the oc-
currence of CeN stretch of amine groups and CeBr stretch of alkyl
Halide [37]. The occurrence of extract associated bonds in ZnOext ap-
proves the link between the two partitions.
TG analysis was conducted to assess the thermal stability of ZnO
samples and approximate the biomolecule content in the ZnOext sample
(Fig. 5a). The ZnOchem sample exhibited a steady weight-loss trend if
compared to the ZnOext sample. This loss could be associated mainly to
the evaporation of the adsorbed water molecules. The weight-loss
Fig. 1. XRD patterns of ZnO nanoparticles synthesized with and without ex- measured at 700 °C for this sample was about 10% if compared to 21%
tract.
for ZnOext. In contrast, the ZnOext sample initially experienced a rapid
weight decay from room temperature up to 250 °C as depicted by the
decolorization at the same concentration of sonocatalytic experiment. slope of the curve for this sample in Fig. 5(a) and this can be associated
100 mg of each ZnO was added to two reaction chambers. The RhB- to the evaporation of absorbed water [38]. The second region of weight-
catalyst mixture was initially stirred for 60 min before being exposed to loss started at 250 °C was observed for this sample and this is believed
a LED-Source (50 W). About 2 mL of mixture was sampled every 30 min, to correspond to the combustion of biomolecules of extract, which was
for 6 h, centrifuged to remove the catalyst, and tested for RhB content connected onto the ZnOext surface.
using a UV–Vis spectrometer. UV–vis DR spectra were provided in the range of 250–850 nm to
investigate the electronic absorption features of the ZnO samples, as
3. Results and discussion depicted in Fig. 5b. A strong characteristic absorption peak at UV wa-
velengths of 365 nm was observed for the ZnOchem sample in the cor-
3.1. Characteristics of the samples responding UV–Vis DR spectrum. Nonetheless, the absorption peak red-
shifted in the case of ZnOext sample, which could be assigned to the
Fig. 1 depicts the XRD patterns of the as-prepared ZnO nano- bonding between the bioactive molecules of the extract and ZnO. The
particles. The diffraction peaks of both samples displayed the crystal- enhanced photo-activity of ZnOext was further confirmed via computing
line structure corresponding to wurtzite hexagonal (JCPDS No. 36- the band gap energies (Eg) of both ZnO samples when the linear area in
3411). The sharpness of the peaks in both spectra is the sign of nano- a plot of (Ahv)2 was extrapolated against (hv) [39]. This provided an
particles of high crystallinity wherein the dissimilarity in particle sizes estimate on the Eg of ZnOchem and ZnOext that were respectively 3.15
gave rise to different peak intensities. The crystallite sizes of the sam- and 2.6 and supported the results.
ples were calculated by Scherrer’s equation [3]. The determined In order to investigate the effect of the extract on the surface
average crystallite sizes for the ZnOchem and ZnOext samples from the characteristics of ZnO, nitrogen absorption-desorption trials were con-
(1 0 1) plane were 27.9 nm and 21 nm, and for (1 1 0) plane were 15 nm ducted and the resulted isotherms are presented in Fig. 5c. The gener-
and 12.4 nm, respectively. The results clearly indicated that the extract ated curves show typical type II isotherms, which disclose the non-
of V. arctostaphylos leaves was effective in controlling the crystallite size porous characteristic of solids. Moreover, the active BET surface areas
of ZnO. of 11.06 m2g−1 and 26.3 m2g−1 were measured for ZnOchem and ZnOext
SEM and TEM analyses were used to study the shape, and size of the samples. As reported in XRD studies, larger surface area of smaller
ZnO samples and the images are shown in Fig. 2. A distinct morphol- ZnOext nanoparticles was expected. Although no remarkable change
ogies were observed for the two samples, i.e. the ZnOchem sample ex- was detected for pore diameters of the samples, the pore volume en-
hibited spindle-shaped particles whereas particles of spherical character hanced in ZnOext sample.
were observed for the ZnOext sample. Although ultrasonically-produced The leaf extract used in the present work is a plentiful source of
ZnO nanoparticles have been reported to form spindle-like shaped active elements, such as phenolics and anthocyanins [30,31]. A number
morphology, in the present work, the extract could have altered the of mechanisms are suggested for the formation of the ZnO nanoparticles
particle shape to spherical [33]. In accordance with XRD results, the in the literature. In a number of studies [40], the phenolic compounds
ZnOext sample can be observed in smaller sizes than the ZnOchem of extract are suggested as the reducing factors in the course of ZnO
sample. This could be attributed to the bioactive compounds of the preparation process. Based on this mechanism, the complexation of
extract, which act as capping agent that control the growth of the Zn2+ ions and hydroxyl groups lead to a p-track conjugation effect [34].
crystallites [34].
EDX analysis was performed to determine the elements present in 3.2. Antidiabetic activities
the ZnOchem and ZnOext samples (Fig. 3). The EDX spectrum of the ZnO
sample that was prepared in water consisted of only two elements, Zn The antidiabetic performance of the bio-fabricated ZnO was eval-
and O. However, in addition to the peaks related to Zn and O, the uated for treating alloxan-diabetic rats after 16 days by measuring the
spectrum of the ZnOext sample encompassed the peaks associated with FBS, insulin, HDL, TC, and TG levels in their blood serums. The results
carbon element which implied the existence of a strong link between were statistically compared to that of achieved by other treatments.
the biomolecules of the extract and ZnO nanoparticles despite re- Alloxan is a hydrophilic diabetogen, which selectively destroys the β-
peatedly washing of the ZnOext sample. cells of pancreas and liver, leading to increased levels of blood glucose
The FT-IR spectra of the ZnO samples are shown in Fig. 4. The wide- upon injection to rats and imposes the diabetic condition [41]. The
ranging absorption band at 3320 cm−1 is assigned to the OeH variations in the blood glucose level in the control and diabetic rats are
stretching vibration of the adsorbed water molecules [35]. Moreover, shown in Fig. 6a and expressed as Mean ± SEM. The results clearly
the absorption peak of ZneO bond located at 550 cm−1 discern the shows that the FBS levels were significantly elevated after alloxan

60
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

Fig. 2. SEM images of (A) ZnOchem and (B) ZnOext. TEM images of (C) ZnOchem, (D) ZnOext and SEM image of (E) ZnOext after photocatalytic process.

injection (p < 0.05). On the 17th day, the recipient group of ZnOext patients, which is mainly concentrated inside the thick core insulin-
nanoparticles showed a significant reduction in FBS level compared to secreting granules (ISG) and in the β cells [45]. On the other hand, the
the diabetic control group. This reduction was significantly lower when interactive effect of extract with ZnO should also be considered wherein
compared with the decreases caused by extract and insulin treatments both ZnO and extract showed lower efficiencies for enhancing insulin
(p < 0.05). Similar results were obtained for those treated by ZnOchem levels when applied solely. It has been reported that whortleberry in-
sample compared to the diabetic control group. However, the difference duces antihyperglycemic effects, which could be associated with con-
between both ZnO samples were not statistically significant. structive secondary metabolites such as anthocyanins, myricetin, and
Data for the effects on the insulin levels after alloxan and treatments chlorogenic acid [46].
injections is shown in Fig. 6b. A significant drop in insulin level was Hyperlipidemia is another complication in diabetic patient that
observed in the diabetic control group compared to that of healthy should be considered as a serious health threat. In this context, the
control group (p < 0.05). However, the level of insulin was re- levels of a number of lipid profiles, vis. HDL, TC, and TG were analyzed
markably enhanced in the ZnOext and insulin-treated groups in com- in the serums and assessed for the studied treatments (Fig. 6c, d, e). In
parison to the diabetic control group (p < 0.05). Though, the differ- advance, the non-treated diabetic rats endured elevated levels of TG
ence in insulin levels induced in the ZnOext and insulin-treated groups along with extremely reduced HDLC levels. Notwithstanding, HDL le-
was not statistically significant. The main insulin-like action of Zn de- vels significantly enhanced in the serums of the rats treated by ZnOext
pends on the glucose transport improvement, along with some other compared to the diabetic control group. On the other hand, ZnOext
intracellular effects [42]. Furthermore, Zn can offer insulin secreta- helped for the TG level reduction. In both cases, the ZnOchem, extract,
gogue activities, since it does not inflict hypoglycemia in organisms and insulin efficiencies were respectively at lower levels. Likewise,
[43]. The influence of Zn on insulin signaling can be explained by ZnOext displayed better effects in reducing TC level. Despite that, other
considering the insulin-like actions of Zn. One example of zinc-depen- treatments did not show major alterations in the levels of serum TC
dent enzyme is insulin-regulated aminopeptidase (IRAP) which is ex- versus the diabetic control rats.
pressed in adipose and muscle tissues as target tissue of insulin and can Dyslipidemia is an important risk factor for atherosclerotic com-
preserve a required glucose transporter-4 level [44]. Normally, the Zn plications of diabetes. The refined lipid profile levels after treating with
content of healthy pancreas is particularly higher than the diabetic ZnOext can be initially assigned to the key role of Zn in a number of

61
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

enhancing the morphology and/or function of β-cells through avoid-


ance of their constant damage, rescue of moderately hurt β-cells, revival
of fresh β-cells, and insulin secretion stimulation [49]. On the other
hand, V. arctostaphylos is characterized with high potentials as anti-
hyperlipidemic mediator, which helps for pulling the lipids and lipo-
proteins levels down in the blood.
As provided from the present study, regardless of the preparation
method, both ZnO samples offered effective risk-reducing interventions
for treating alloxan-diabetic rats. In point of fact, the imperative role of
zinc in several cell functions need to be taken into account. Diabetes is
associated with the Zn insufficiency as it is a unit of insulin.
Administration of Zn to diabetic patients have generally shown positive
effects, especially among type 2 diabetic patients who have a Zn defi-
ciency [43]. This trace element is a significant nutrient, and cofactor of
several enzymes, which performs as a mediator for intracellular sig-
naling. Zn has found to be involved in effective utilization and meta-
bolism of glucose via its effect on the pathway of insulin signaling,
which in turn enhances the hepatic glycogenesis [50]. On the other
hand, the secondary metabolites of the V. arctostaphylos leaf extract
have shown healing properties to control diabetes mellitus [49]. From
the results, it can be concluded that the in cooperation of ZnO and
extract can induce a synergistic effect, which promote the antidiabetic
action of ZnOext nanoparticles.

3.3. Antibacterial activity

At the next step, a set of contrastive studies were conducted to assess


the prospective antibacterial activity of the ZnO nanoparticles synthe-
sized with and without whortleberry leaf extract. Fig. 7a, b display the
antibacterial results of both ZnO samples at the concentrations ranging
from 0.05 to 0.8 mg/mL against S. aureus and E. coli. Both samples
exhibited great performances for destruction of the studied bacteria, as
exposed from the survival rate results and pure culture images. More-
over, the data correspond to minimum inhibitory concentration (MIC)
and none inhibitory concentration (NIC) results of the samples revealed
the MIC of 0.4 mg/mL against S. aureus. Besides bacterial duplication
inhibition at ZnOext of 0.8 mg/mL, the bacteria was destroyed as well.
Fig. 3. The EDX spectra of ZnO nanoparticles. In the case of E. coli, both ZnO samples performed similarly wherein
MIC of 0.8 was obtained for either. This dominance can be primarily
elucidated by ZnO ability to produce reactive oxygen species such as

OH radicals wherein the cell membrane is damaged by these radicals
which ultimately kills bacteria. Moreover, the intracellular accumula-
tion of ZnO nanoparticles and released Zn2+ ions are reported as other
mechanisms involved in the ZnO antibacterial action [25,26].
At the same time, the anti-pathogenic role of the organic moieties
over ZnOext should not be neglected as they include heterocyclic and
phenolic compounds. The antibacterial results established that the bio-
synthesizing of ZnO NPs by leaf extract of V. arctostaphylos encompass
of inherently active antimicrobial biomolecules strongly prevented the
growth of the gram-positive bacteria and enhanced antimicrobial per-
formance of ZnO nanoparticles.

3.4. Oxidative performance

Rhodamine B (RhB) was chosen as the model organic compound to


Fig. 4. FT-IR spectra of whortleberry extract, and ZnO samples. assess the plausible effect of V. arctostaphylos leaf extract on the oxi-
dative activity of ZnO nanoparticles. In this regard, an LED source of
enzymatic reactions. Zn acts similar to α-blocker, as proven in the light was used to activate the ZnO nanoparticles. Fig. 8a shows the
short-term treatment of dyslipidemia [47]. The results were in good optical absorption of the RhB aqueous solution before and during the
agreement with related literature, which indicate the fundamental ac- photocatalytic reaction of both ZnO samples. The degradation effi-
tion of zinc in metalloenzymes in charge for the lipid digestion and ciency (%) was gradually decreased as the reaction proceeded, in-
absorption [48]. Apart from that, the water extract of V. arctostaphylos dicating the prominent degradation of RhB under the light irradiation.
was found effective in dealing with dyslipidemia as a fatal aspect for Ultimately, RhB was totally removed by both samples after 270 min of
atherosclerotic complications in diabetes. The organic moieties and photocatalytic reaction. Although the photocatalytic DE% of ZnOchem
secondary metabolites in V. arctostaphylos are reportedly involved in and ZnOext was not remarkably different at 270 min, it can be seen from
the figure that ZnOext showed higher efficiencies during the studied

62
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

Fig. 5. (a) TGA charts, (b) UV–vis DRS, and (c) Isotherms of nitrogen adsorption-desorption of ZnO samples.

reaction time especially between 60 and 180 min. This can be assigned either adsorbed H2O or surface eOH groups to form hydroxyl radicals.
to the reduction in the band gap energy of ZnO when enriched by the Consequently, more RhB molecules could be decomposed by ZnOext
extract (Eg = 2.7), which brought about easier activation of the sample. sample compared to ZnOchem. It should be noted that the amount of the
The SEM images of the ZnOext sample is also obtained after its appli- linked biomolecules were very low, thus not impeding the photo-
cation in the photocatalytic system (Fig. 2E) and compared to that catalytic activity of ZnO via absorbing the incident light.
obtained earlier. No obvious changes in the morphology and size of the
sample was observed, except the aggregation of the particles. This is
because the sonication process during the synthesis of the sample 4. Conclusion
helped for well-distribution of particles, while this factor was absent
during the photocatalytic activity. Diabetes is a multifactorial disease, yet is not easily controlled and
At the next step, ultrasound irradiation took the place of light source treated. This study assessed the synergistic effects of Zn, as a key ele-
in order to evaluate the oxidative performance of both ZnO samples as ment in various cellular bio-processes, and V. arctostaphylos leaf extract
sonocatalyts. The activity of ZnOext and ZnOchem were comparable with antidiabetic properties when present together for treating alloxan-
wherein both of them effectively removed RhB within 240 and 270 min, diabetic rats. The characterization results exposed that ZnO nano-
respectively (Fig. 8b). In this case, the sonocatalytic performance of particles grew in smaller sizes when prepared with V. arctostaphylos leaf
biologically produced ZnO was also higher than chemically produced extract. The company of whortleberry phytochemicals over ZnOext was
sample, primarily eventuated from the large number of the generated verified by EDX, FT-IR, TGA, and UV–vis DRS techniques. All the stu-
holes under the influence of ultrasound irradiation and long lifespan of died treatments exhibited good antidiabetic activities for handling the
charge carriers due to the electron-capturing by phenolic compounds of complications associated with diabetes. Nonetheless, ZnOext showed the
extract. best performance for lowering the FBS, TC, and TG levels and pro-
From the oxidative experiments, ZnOext showed higher activities for moting the insulin and HDL levels in alloxan-diabetic rats in contrast to
degradation of RhB under both photo and sono illumination. This can other treatments. Additionally, the green synthesized sample showed
be explained as follows: when ZnO nanoparticles are irradiated with great efficiencies against microbial and organic pollutants. The domi-
photons, the excitation of electrons from the valence band to the con- nant action of ZnOext in contrast to ZnOchem and only extract clearly
duction band of ZnO is occurred that induces electron-hole pairs (e−/ indicate the synergy between them. The results obtained from this
h+). As above mentioned, the excitation of electrons and generation of study strongly proves that the application of V. arctostaphylos leaf ex-
holes are easier in ZnOext owing to its smaller band gap energy. These tract during the synthesis prevents the chemical pollution and em-
e−/h+ either recombine together or transfer to the photocatalyst sur- powers the resulted ZnO towards effective antidiabetic, antibacterial,
face to begin the photocatalytic reactions. In the case of ZnOext, the and oxidative performances.
present phenolic compounds capture the generated electrons, leaving
the holes free for reactions. Subsequently, the holes can react with

63
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

Fig. 6. (a) FBS, (b) Insulin, (c) HDL, (d) CT, and (e) TG levels in the studied groups during the experiments.

Fig. 7. Antibacterial activities of ZnO samples against (a) gram-positive, and (b) gram-negative bacteria.

64
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

Fig. 8. (a) photocatalytic and (b) sonocatalytic activities of ZnO samples for removing RhB (Experimental condition: pH = unchanged; [RhB]: 5 mg/L; LED lamp;
Catalyst: 0.1 g/L; and Ultrasound frequency = 20 kHz).

Acknowledgement [18] J.C. Fernández-Cao, M. Warthon-Medina, V.H. Moran, V. Arija, C. Doepking,


N.M. Lowe, Dietary zinc intake and whole blood zinc concentration in subjects with
type 2 diabetes versus healthy subjects: a systematic review, meta-analysis and
The support provided by the University of Mohaghegh Ardabili meta-regression, J. Trace Elem. Med. Biol. (2018).
(Iran) is greatly acknowledged. [19] X.-H. Tang, N.F. Shay, Zinc has an insulin-like effect on glucose transport mediated
by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes, J. Nutr.
131 (2001) 1414–1420.
References [20] Z. Kiss, K.S. Crilly, M. Tomono, Bombesin and zinc enhance the synergistic mito-
genic effects of insulin and phosphocholine by a MAP kinase-dependent mechanism
[1] O. Mahian, L. Kolsi, M. Amani, P. Estellé, G. Ahmadi, C. Kleinstreuer, J.S. Marshall, in Swiss 3T3 cells, FEBS Lett. 415 (1997) 71–74.
R.A. Taylor, E. Abu-Nada, S. Rashidi, H. Niazmand, S. Wongwises, T. Hayat, [21] J. Park, J.Y. Koh, Induction of an immediate early gene egr-1 by zinc through ex-
A. Kasaeian, I. Pop, Recent advances in modeling and simulation of nanofluid tracellular signal-regulated kinase activation in cortical culture, J. Neurochem. 73
flows—part II: applications, Phys. Rep. 791 (2019) 1–59. (1999) 450–456.
[2] S. Rostamnia, E. Doustkhah, Nanoporous silica-supported organocatalyst: a het- [22] Y. Liu, L. He, A. Mustapha, H. Li, Z.Q. Hu, M. Lin, Antibacterial activities of zinc
erogeneous and green hybrid catalyst for organic transformations, RSC Adv. 4 oxide nanoparticles against Escherichia coli O157:H7, J. Appl. Microbiol. 107
(2014) 28238–28248. (2009) 1193–1201.
[3] D. Dastan, P.U. Londhe, N.B. Chaure, Characterization of TiO2 nanoparticles pre- [23] Y. Xie, Y. He, P.L. Irwin, T. Jin, X. Shi, Antibacterial activity and mechanism of
pared using different surfactants by sol-gel method, J. Mater. Sci.: Mater. Electron. action of zinc oxide nanoparticles against Campylobacter jejuni, Appl. Environ.
25 (2014) 3473–3479. Microbiol. 77 (2011) 2325–2331.
[4] P. Kanmani, J.-W. Rhim, Properties and characterization of bionanocomposite films [24] A. Azam, A.S. Ahmed, M. Oves, M.S. Khan, S.S. Habib, A. Memic, Antimicrobial
prepared with various biopolymers and ZnO nanoparticles, Carbohydr. Polym. 106 activity of metal oxide nanoparticles against Gram-positive and Gram-negative
(2014) 190–199. bacteria: a comparative study, Int. J. Nanomed. 7 (2012) 6003–6009.
[5] M. Pirhashemi, A. Habibi-Yangjeh, S. Rahim Pouran, Review on the criteria an- [25] Q. Li, S. Mahendra, D.Y. Lyon, L. Brunet, M.V. Liga, D. Li, P.J.J. Alvarez,
ticipated for the fabrication of highly efficient ZnO-based visible-light-driven pho- Antimicrobial nanomaterials for water disinfection and microbial control: potential
tocatalysts, J. Ind. Eng. Chem. 62 (2018) 1–25. applications and implications, Water Res. 42 (2008) 4591–4602.
[6] L.-E. Shi, Z.-H. Li, W. Zheng, Y.-F. Zhao, Y.-F. Jin, Z.-X. Tang, Synthesis, anti- [26] J. Pasquet, Y. Chevalier, J. Pelletier, E. Couval, D. Bouvier, M.-A. Bolzinger, The
bacterial activity, antibacterial mechanism and food applications of ZnO nano- contribution of zinc ions to the antimicrobial activity of zinc oxide, Colloids Surf. A
particles: a review, Food Addit. Contam. Part A 31 (2014) 173–186. 457 (2014) 263–274.
[7] H. Agarwal, S. Venkat Kumar, S. Rajeshkumar, A review on green synthesis of zinc [27] S. Sedaghathoor, A. Kashi, A. Talaei, A. Khalighi, Essential oils of Qare-Qat
oxide nanoparticles – an eco-friendly approach, Resour. Eff. Technol. 3 (2017) (Vaccinium arctostaphylos) shoots and chemical composition of berries, Int. J.
406–413. Agric. Biol. 8 (2006) 45–46.
[8] P. Kuppusamy, M.M. Yusoff, N.R. Parine, N. Govindan, Evaluation of in-vitro an- [28] R. Soltani, M. Hakimi, S. Asgary, S.M. Ghanadian, M. Keshvari, N. Sarrafzadegan,
tioxidant and antibacterial properties of Commelina nudiflora L. extracts prepared Evaluation of the effects of Vaccinium arctostaphylos L. fruit extract on serum lipids
by different polar solvents, Saudi, J. Biol. Sci. 22 (2015) 293–301. and hs-CRP levels and oxidative stress in adult patients with hyperlipidemia: a
[9] S. Jeyabharathi, K. Kalishwaralal, K. Sundar, A. Muthukumaran, Synthesis of zinc randomized, double-blind, placebo-controlled clinical trial, Evidence-Based
oxide nanoparticles (ZnONPs) by aqueous extract of Amaranthus caudatus and Complem. Alternative Med: eCAM (2014) 1–6.
evaluation of their toxicity and antimicrobial activity, Mater. Lett. (2017). [29] B. Nickavar, G. Amin, Enzyme assay guided isolation of an α-amylase inhibitor
[10] F. Mohammadi Arvanag, A. Bayrami, A. Habibi-Yangjeh, S. Rahim, Pouran, A flavonoid from vaccinium arctostaphylos leaves, Iran. J. Pharm. Res. 10 (2011)
comprehensive study on antidiabetic and antibacterial activities of ZnO nano- 849–853.
particles biosynthesized using Silybum marianum L seed extract, Mater. Sci. Eng., C [30] V.V. Mzhavanadze, I.L. Targamadze, L.I. Dranik, Phenolic compounds of the leaves
97 (2019) 397–405. of Vaccinium arctostaphylos, Chem. Nat. Compd. 8 (1972) 125–126.
[11] K. Shanker, J. Naradala, G.K. Mohan, G. Kumar, P. Pravallika, A sub-acute oral [31] A.K. Latti, P.S. Kainulainen, S. Hayirlioglu-Ayaz, F.A. Ayaz, K.R. Riihinen,
toxicity analysis and comparative in vivo anti-diabetic activity of zinc oxide, cerium Characterization of anthocyanins in Caucasian blueberries (Vaccinium arctosta-
oxide, silver nanoparticles, and Momordica charantia in streptozotocin-induced phylos L.) native to Turkey, J. Agric. Food Chem. 57 (2009) 5244–5249.
diabetic Wistar rats, RSC Adv. 7 (2017) 37158–37167. [32] A. Azary, A. Bezaatpour, S. Zahri, M. Amiri, Synthesis, characterization, crystal
[12] S.S. Momeni, M. Nasrollahzadeh, A. Rustaiyan, Green synthesis of the Cu/ZnO structure, electrochemical, solvatochromic and biological investigation of novel N4
nanoparticles mediated by Euphorbia prolifera leaf extract and investigation of and N3 type Cu (II) Schiff base complexes, New J. Chem. 41 (2017) 12554–12561.
their catalytic activity, J. Colloid Interface Sci. 472 (2016) 173–179. [33] N. Kumar, H. Mittal, L. Reddy, P. Nair, J.C. Ngila, V. Parashar, Morphogenesis of
[13] H. Padalia, S. Chanda, Characterization antifungal and cytotoxic evaluation of ZnO nanostructures: role of acetate (COOH−) and nitrate (NO3−) ligand donors
green synthesized zinc oxide nanoparticles using Ziziphus nummularia leaf extract, from zinc salt precursors in synthesis and morphology dependent photocatalytic
Artif. Cells Nanomed. Biotechnol. (2017) 1–14. properties, RSC Adv. 5 (2015) 38801–38809.
[14] H. Xu, Y. Zhang, C. He, Ultrasonically assisted extraction of isoflavones from stem of [34] A. Bayrami, S. Parvinroo, A. Habibi-Yangjeh, S. Rahim Pouran, Bio-extract-medi-
Pueraria lobata (Willd.) Ohwi and its mathematical model, Chin. J. Chem. Eng. 15 ated ZnO nanoparticles: microwave-assisted synthesis, characterization and anti-
(2007) 861–867. diabetic activity evaluation, Artif. Cells Nanomed. Biotechnol. (2017) 1–10.
[15] A. Khataee, A. Karimi, S. Arefi-Oskoui, R. Darvishi Cheshmeh Soltani, [35] V. Srivastava, D. Gusain, Y.C. Sharma, Synthesis, characterization and application
Y. Hanifehpour, B. Soltani, S.W. Joo, Sonochemical synthesis of Pr-doped ZnO of zinc oxide nanoparticles (n-ZnO), Ceram. Int. 39 (2013) 9803–9808.
nanoparticles for sonocatalytic degradation of Acid Red 17, Ultrason. Sonochem. 22 [36] N.F. Djaja, D.A. Montja, R. Saleh, The effect of Co incorporation into ZnO nano-
(2015) 371–381. particles, Adv. Mater. Phys. Chem. 3 (2013) 33.
[16] J.B. Meigs, Epidemiology of the metabolic syndrome, Am. J. Manag. Care 8 (2002) [37] J. Santhoshkumar, S.V. Kumar, S. Rajeshkumar, Synthesis of zinc oxide nano-
S283–S292 quiz S293-286. particles using plant leaf extract against urinary tract infection pathogen, Resour.
[17] R.E. Warren, The stepwise approach to the management of type 2 diabetes, Diabetes Eff. Technol. 3 (2017) 459–465.
Res. Clin. Pract. 65 (2004) S3–S8. [38] D. Dastan, Effect of preparation methods on the properties of titania nanoparticles:

65
A. Bayrami, et al. Ultrasonics - Sonochemistry 55 (2019) 57–66

solvothermal versus sol-gel, Appl. Phys. A 123 (2017) 699. vesicles, J. Biol. Chem. 270 (1995) 23612–23618.
[39] A. Khataee, R. Hassandoost, S. Rahim Pouran, Cerium-substituted magnetite: fab- [45] P. Chabosseau, G.A. Rutter, Zinc and diabetes, Arch. Biochem. Biophys. 611 (2016)
rication, characterization and sonocatalytic activity assessment, Ultrason. 79–85.
Sonochem. 41 (2018) 626–640. [46] S. Kianbakht, B. Abasi, F.H. Dabaghian, Anti-hyperglycemic effect of vaccinium
[40] P. Velmurugan, J.-H. Park, S.-M. Lee, Y.-J. Yi, M. Cho, J.-S. Jang, H. Myung, K.- arctostaphylos in type 2 diabetic patients: a randomized controlled trial,
S. Bang, B.-T. Oh, Eco-friendly approach towards green synthesis of zinc oxide Complementary Med. Res. 20 (2013) 17–22.
nanocrystals and its potential applications, Artif. Cells Nanomed. Biotechnol. 44 [47] D. Patel, R. Kumar, S. Prasad, K. Sairam, S. Hemalatha, Antidiabetic and in vitro
(2016) 1537–1543. antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-
[41] J. Raju, J.M. Patlolla, M.V. Swamy, C.V. Rao, Diosgenin, a steroid saponin of induced diabetic rats, Asian Pac, J. Trop. Biomed. 1 (2011) 316–322.
Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant [48] H.J. Al-Daraji, M.H. Amen, Effect of dietary zinc on certain blood traits of broiler
crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon breeder chickens, Int. J. Poult. Sci. 10 (2011) 807–813.
cancer cells, Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1392–1398. [49] M. Bahmani, H. Golshahi, K. Saki, M. Rafieian-Kopaei, B. Delfan, T. Mohammadi,
[42] J.M. May, C. Contoreggi, The mechanism of the insulin-like effects of ionic zinc, J. Medicinal plants and secondary metabolites for diabetes mellitus control, Asian Pac.
Biol. Chem. 257 (1982) 4362–4368. J. Trop. Dis. 4 (2014) S687–S692.
[43] J. Rungby, Zinc, zinc transporters and diabetes, Diabetologia 53 (2010) 1549–1551. [50] A. Alkaladi, A.M. Abdelazim, M. Afifi, Antidiabetic activity of zinc oxide and silver
[44] S.R. Keller, H.M. Scott, C.C. Mastick, R. Aebersold, G.E. Lienhard, Cloning and nanoparticles on streptozotocin-induced diabetic rats, Int. J. Mol. Sci. 15 (2014)
characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 2015–2023.

66

You might also like